Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
124.4 USD | +1.70% | +3.21% | -10.86% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.86% | 19.47B | |
+8.37% | 219B | |
+6.37% | 183B | |
+10.64% | 133B | |
+24.86% | 108B | |
+0.27% | 63.06B | |
+12.01% | 52.02B | |
+3.96% | 48.2B | |
-0.04% | 40.37B | |
+14.67% | 39.35B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail